Gancyclovir delivery provides for cell kill selecting for transfected cells.
Phase II study of I-131 labeled antibodies to DNA histones for newly diagnosed or recurrent Glioblastoma Multiforme. Phase I study of photodynamic laser therapy for newly diagnosed Glioblastomoa Multiforme. Phase I study of tumor peptide-pulsed dendritic cell immunotherapy for newly diagnosed or recurrent malignant glioma. RMP-7 is a bradykinin analog that temporarily increases permeability of the BBB to allow better delivery of anti tumor agents. Brain Tumor Immuno-gene therapy Development of Dendritic Cell based vaccines.